VEGF antibody | Bevacizumab
Human anti VEGF (Bevacizumab Biosimilar)
- Product Type
- Monoclonal Antibody
- Clone
- Bevacizumab
- Isotype
- IgG1
- Specificity
- VEGF
Human Anti-VEGF antibody is a research grade biosimilar of the monoclonal antibody drug bevacizumab. This product is supplied in a research grade format, i.e. in PBS buffer with preservative, it is not manufactured or formulated in the same way as the therapeutic reference product. A preservative free version is available on request. This product is a recombinant human IgG1 kappa antibody with variable regions from the therapeutic bevacizumab antibody clone. This antibody is for research use only. It is suitable as a reference standard in a pharmacokinetic (PK) bridging ELISA with anti-bevacizumab antibodies, for example HCA182 and HCA185. It can also be used as capture and detection reagent in an anti-drug antibody (ADA) bridging ELISA, with an anti-bevacizumab antibody in IgG1 format as a reference standard, for example HCA184 or HCA185. Bevacizumab, also known as Avastin, is a humanized monoclonal antibody (IgG1 kappa) that inhibits angiogenesis by binding to VEGF-A. VEGF-A stimulates new blood vessel formation in certain diseases, especially in cancer. Avastin is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian. This product is NOT FOR THERAPEUTIC USE. View a summary of supporting anti-bevacizumab antibody products. |
- Target Species
- Human
- Product Form
- Human IgG1 (kappa) antibody - liquid
- Preparation
- Purified recombinant IgG prepared by affinity chromatography on Protein A from a mammalian cell line
- Source
- HEK
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.02% ProClin 300
- Immunogen
- Human VEGF
- Purity
- >98% by SDS PAGE
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
- Acknowledgements
- ProClin is a trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow.
- Licensed Use
- For in vitro research purposes only. Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
Application Name | Verified | Min Dilution | Max Dilution |
---|---|---|---|
ELISA |
Description | Product Code | Applications | Pack Size | List Price | Your Price | Quantity | |
---|---|---|---|---|---|---|---|
Hispec Assay Diluent | BUF049A | E IY | 50 ml | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Hispec Assay Diluent | ||||||
Human anti Bevacizumab | HCA182 | E | 0.1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Human anti Bevacizumab | ||||||
Human anti Bevacizumab | HCA184 | E | 0.1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Human anti Bevacizumab | ||||||
Human anti Bevacizumab:HRP | HCA184P | E | 0.1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Human anti Bevacizumab:HRP | ||||||
Human anti Bevacizumab | HCA185 | E | 0.1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Human anti Bevacizumab | ||||||
LYNX Rapid HRP Antibody Conjugation Kit | LNK001P | CJ | 1 Conjugation For 400µg Antibody | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | LYNX Rapid HRP Antibody Conjugation Kit |
MCA6089
151959 153789 158630 170620If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
View all Anti-Human ProductsAlways be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up